Novonesis
NZYM.VIPhase 2Novonesis operates as a major biotechnology platform company focused on developing and commercializing enzyme-based solutions for diverse markets. With its Danish headquarters and significant market presence, the company leverages advanced biotechnology to create sustainable solutions across healthcare, industrial, and agricultural sectors. The company's substantial market valuation of $25.2 billion reflects its established position in the global biotechnology landscape.
NZYM.VI · Stock Price
Historical price data
AI Company Overview
Novonesis operates as a major biotechnology platform company focused on developing and commercializing enzyme-based solutions for diverse markets. With its Danish headquarters and significant market presence, the company leverages advanced biotechnology to create sustainable solutions across healthcare, industrial, and agricultural sectors. The company's substantial market valuation of $25.2 billion reflects its established position in the global biotechnology landscape.
Technology Platform
Biotechnology platform company focused on enzyme solutions and biotechnology innovations across multiple industries including healthcare, agriculture, and industrial applications.
Pipeline Snapshot
11 drug in pipeline
| Drug | Indication | Stage |
|---|---|---|
| lactobacilus acidophilus & bifidobacterium animalis/lactis | Ulcerative Colitis | Phase 2 |
Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive biotechnology sector alongside enzyme manufacturers, industrial biotechnology companies, and specialty chemical producers. The company's substantial market valuation suggests competitive advantages and market differentiation.
Company Info
Trading
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile